Delayed, severe thrombocytemia after abciximab infusion for primary angioplasty in acute coronary syndromes: Moving between systemic bleeding and stent thrombosis

Platelets. 2015;26(5):498-500. doi: 10.3109/09537104.2014.898181. Epub 2014 Mar 28.

Authors

Luca Giupponi¹, Silvia Cantoni, Nuccia Morici, Alice Sacco, Cristina Giannattasio, Silvio Klugmann, Stefano Savonitto

Affiliation

¹ Niguarda Ca' Granda Hospital and Milano-Bicocca University , Milan , Italy .

PMID: 24678647
DOI: 10.3109/09537104.2014.898181

No abstract available

Keywords: Abciximab; acute coronary syndrome; myocardial infarction; prasugrel; thrombocytopenia.

Publication types

Case Reports
Letter

MeSH terms

Abciximab
Acute Coronary Syndrome / complications*
Acute Coronary Syndrome / therapy*
Angioplasty / methods*
Antibodies, Monoclonal / administration & dosage*
Hemorrhage / etiology
Humans
Immunoglobulin Fab Fragments / administration & dosage*
Male
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage*
Severity of Illness Index
Stents / adverse effects
Thrombocytosis / diagnosis*
Thrombocytosis / etiology*
Thrombosis / etiology

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Abciximab